𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase I–II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies

✍ Scribed by Terence S Herman; Maxine S Jochelson; Beverly A Teicher; Pamela J Scott; Jorgen Hansen; John R Clark; M.Raphael Pfeffer; Lise E Gelwan; Beverly J Molnar-Griffin; Suzette M Fraser; Goran Svennson; Bruce A Bornstein; L Ryan; C.Norman Coleman


Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
911 KB
Volume
17
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A phase I trial of dactinomycin intraven
✍ Martin S. Blumenreich; Thomas M. Woodcock; Stephen P. Richman; Mariesa K. Jones; 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 3 views

Eighteen patients with advanced malignancies refractory to other forms of treatment were given dactinomycin (Act D) as continuous intravenous infusions. Their median age was 51 years (range, 36-67); their median performance status was 50 (range, 40-90) on the Karnofsky scale. Act D was administered

A phase II trial of neoadjuvant methotre
✍ Louise E. Morrell; Young J. Lee; Judith Hurley; Mayda Arias; Carolyn Mies; Steph 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Traditionally, primary surgical therapy is considered unsuitable for the treatment of patients with locally advanced breast carcinoma (labc). multiple reports have documented the efficacy of primary chemotherapy in this group of patients. the purpose of this study was to investigate

A pilot Phase II trial of concurrent rad
✍ Ellen L. Jones; Thaddeus V. Samulski; Mark W. Dewhirst; Angeles Alvarez-Secord; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract ## BACKGROUND Five randomized studies have demonstrated a benefit derived from adding cisplatin (CDDP)‐based chemotherapy to radiotherapy (RT) for treatment of cervical carcinoma. The Dutch Phase III pelvic tumor trial demonstrated a survival and local control benefit due to the additi

Phase I/II trial of combined 131I anti-C
✍ Bharat B. Mittal; Michael A. Zimmer; Vythialingam Sathiaseelan; Al B. Benson III 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 939 KB

BACKGROUND. This pilot project was undertaken to evaluate the toxicity of and tumor response to combined 13'1 anti-carcinoembryonic antigen monoclonal antibody ('"I anti-CEA RMoAb) and hyperthermia in patients with metastatic colorectal adenocarcinoma.